Aspiro Pharma Limited, a active public limited company, was established on 05 February 2014 in Markook, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100TG2014PLC092771. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1,470.10 Cr and a paid-up capital of ₹1,004.15 Cr.
It upholds a compliant status. Employing 408 professional, Its leadership includes Bandi Vamsikrishna (Director), Reddy Narsimha (Director), Krishnaveni Kura (Director). Past directors included Gopala Krishna Rampalli, Venkateswarreddy Sandadi, Buchiram Venkat Sobhanadri Suri. It holds ₹206.91 Cr open charges and ₹46.89 Cr settled loans. Its latest AGM occurred on 24 July 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. 23, Survey No.321, Biotech Park Phase-Iii, Karkapatla Villa, Ge,, Markook, Telangana, 502281.
U24100TG2014PLC092771
092771
05 February 2014
₹1,470.10 Cr
₹1,004.15 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Aspiro Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bandi Vamsikrishna | Director | 13 Feb 2014 | Current |
| Reddy Narsimha | Director | 03 Aug 2024 | Current |
| Krishnaveni Kura | Director | 29 Jun 2017 | Current |
| Ramaseshappa Siva Prasad Panchangam | Additional Director | 03 Aug 2023 | Current |
| Mahesh Ramappa Kamalamma Hassan | Director | 07 Jun 2023 | Current |
| Bhaskarreddy Pabbatireddy | Additional Director | 10 Oct 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 17 Aug 2017 | Past |
| Pramod Abcsdd | Director | 13 Feb 2014 | Past |
| Pramod Abcsdd | Additional Director | 17 Aug 2017 | Past |
| Pramod Abcsdd | Additional Director | 25 Sep 2014 | Past |
| Pramod Abcsdd | Director | 13 Feb 2014 | Past |
| Pramod Abcsdd | Additional Director | 18 Aug 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aspiro Pharma Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.47% increase. The company also saw a substantial fall in profitability, with a 69.63% decrease in profit. The company's net worth observed a substantial decline by a decrease of 21.68%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Aspiro Pharma had a promoter holding of 99.83% and a public holding of 0.17%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,069,111,003.00
₹468,900,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Sep 2024 | Others | ₹100.00 Cr | Open |
| 10 May 2024 | Others | ₹0.90 M | Open |
| 03 Apr 2024 | Others | ₹105.00 Cr | Open |
| 04 Nov 2023 | Others | ₹1.30 M | Open |
| 26 Oct 2023 | Others | ₹1.02 M | Open |
Explore comprehensive loan charge details -
Aspiro Pharma has a workforce of 408 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Aspiro Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aspiro Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Bhaskarreddy Pabbatireddy was appointed as a Additional Director was appointed as a Additional Director on 10 Oct 2025 & has been associated with this company since 3 months 6 days . was recorded as a recent event.
Aspiro Pharma Limited last Annual general meeting of members was held on 24 Jul 2025 as per latest MCA records. was recorded as a recent event.
The activity Aspiro Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.
A charge registered on 29 Apr 2015 via Charge ID 10569865 with State Bank Of Mysore was fully satisfied on 18 Nov 2024. was recorded as a recent event.
A charge with Others amounted to Rs. 100.00 Cr with Charge ID 100989753 was registered on 30 Sep 2024. was recorded as a recent event.
Progress on Reddy Narsimha was appointed as a Director was appointed as a Director on 03 Aug 2024 & has been associated with this company since 1 year 5 months . was documented.
The CIN of Aspiro Pharma Limited is U24100TG2014PLC092771.
Aspiro Pharma Limited is headquartered at Plot No. 23, Survey No.321, Biotech Park Phase-Iii, Karkapatla Villa, Ge,, Markook, Telangana, 502281.
Aspiro Pharma Limited was incorporated on 05 February 2014.
The current directors of Aspiro Pharma Limited are
The primary industry of Aspiro Pharma Limited is Manufacturing.
Aspiro Pharma Limited is unlisted.
The authorized capital of Aspiro Pharma Limited is ₹1,470.10 Cr, and the paid-up capital is ₹1,004.15 Cr.
The compliance status of Aspiro Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX